Multiple myeloma

Multiple myeloma (MM) is a malignant tumor of plasma cell characterized by overproduction of abnormal plasma cells in the bone marrow and skeletal destruction. The clinical features are bone pain, renal impairment, immunodeficiency, anemia and presence of abnormal immunoglobulins (Ig).

Pulmonary infiltrates



Total: 3

                       


(per page)
PMID (PMCID)
20376900
(2852803)
 MALE
Nonspecific interstitial pneumonitis after bortezomib and thalidomide treatment in a multiple myeloma patient.
Kang W, Kim JS, Cho SH, Kim SK, Chang J, Park MS.
Yonsei Med J. 2010;51(3):448-50.
Here, we describe a patient with dyspnea and diffuse pulmonary infiltrates while receiving bortezomib and thalidomide in combination with dexamethasone for treatment-naive multiple myeloma.
8669193
 MALE Middle Aged
Cytologic manifestations of respiratory syncytial virus pneumonia in bronchoalveolar lavage fluid: a case report.
Zaman SS, Seykora JT, Hodinka RL, Gupta PK, Pietra GG.
Acta Cytol. 1996;40(3):546-51.
A 45-year-old male with multiple myeloma who underwent autologous peripheral stem cell transplantation subsequently developed bilateral pulmonary infiltrates.
904351
 MIXED_SAMPLE
Early pleural decortication for thoracic empyema in immunosuppressed patients.
Fishman NH, Ellertson DG.
J Thorac Cardiovasc Surg. 1977;74(4):537-41.
They were immunodeficient because of (1) high-dose steroids (HDS) for sagittal sinus thrombosis, (2) HDS for systemic lupus erythematosus, (3) HDS for chronic myelogenous leukemia and myelofibrosis, (4) HDS for multiple myeloma, (5) hemolytic anemia with pulmonary infiltrates, (6) chemotherapy for Hodgkin's disease, (7) diabetes mellitus with Kimmelstiel-Wilson disease, and (8) diabetes mellitus with chronic glomerulonephritis.